kabutan
N225

65,416.63

+2.17%

TOPIX

3,896.11

+1.14%

USDJPY

160.19

+0.01%

Kidswell Bio, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.

Thu May 14, 2026 4:00 pm JST Earnings

4584 Kidswell Bio Corporation 【J-GAAP】

Earnings Report

Kidswell Bio Corporation <4584> [TSE Growth] announced its financial results after the market closed on May 14th (16:00). The consolidated net loss for the fiscal year ended March 2026 expanded to a loss of 0.41 billion yen (compared to a loss of 0.02 billion yen in the previous period). This marks the nineteenth consecutive term of losses. Furthermore, the company projects revenue in the range of 5.00 billion to 6.00 billion yen for the fiscal year ending March 2027.

In the most recent three-month period, from January to March (4Q), the consolidated net income/loss turned to a loss of 0.27 billion yen (compared to a profit of 0.16 billion yen in the same period last year). The operating profit/loss margin drastically worsened from 8.0% in the same period last year to -14.1%.

Kabutan News

Actual Performance and Financial Trends

Historical Performance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj. Dividend Announce Accounting
Standards
Mar, 2024
2,431M -1,335M -1,389M -1,422M -40.2 0 May 14, 2024 J-GAAP
Mar, 2025
5,082M 27M 5M -21M -0.5 0 May 13, 2025 J-GAAP
Mar, 2026
6,589M -138M -374M -413M -8.5 0 May 14, 2026 J-GAAP
YoY +29.7% -1,866.7% -1,530.8%
Full Year Results vs. Previous Guidance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Mar, 2026 Guidance 6,250M 0M 0 Feb 12, 2026 J-GAAP
Mar, 2026 Results 6,589M -138M -374M -413M -8.5 0 May 14, 2026 J-GAAP
Revision Rate +5.4%

Current Period Guidance

First Half Results
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Apr - Sep, 2025
3,276M 215M 76M 60M 1.3 0 Nov 13, 2025 J-GAAP
Guidance
Apr - Sep, 2026
0 May 14, 2026 J-GAAP
YoY
Current Period Guidance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Mar, 2025
5,082M 27M 5M -21M -0.5 0 May 13, 2025 J-GAAP
Mar, 2026
6,589M -138M -374M -413M -8.5 0 May 14, 2026 J-GAAP
Guidance
Mar, 2027
5,500M 350M 0 May 14, 2026 J-GAAP
YoY -16.5%

Quarterly Results

Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Operating
Profit Margin
Announce Accounting
Standards
Jan - Mar, 2025
2,046M 164M 166M 166M 4.1 8.0 May 13, 2025 J-GAAP
Apr - Jun, 2025
1,720M 184M 175M 157M 3.3 10.7 Aug 13, 2025 J-GAAP
Jul - Sep, 2025
1,556M 31M -99M -97M -2.0 2.0 Nov 13, 2025 J-GAAP
Oct - Dec, 2025
1,742M -131M -210M -202M -4.2 -7.5 Feb 12, 2026 J-GAAP
Jan - Mar, 2026
1,571M -222M -240M -271M -5.6 -14.1 May 14, 2026 J-GAAP
YoY -23.2%